Search results for

Masanori Tosu On November 25 2014, an amendment to the Pharmaceuticals and Medical Devices Law (the Law) came into effect and introduced important changes to Japan's medical products regulatory regime, including the establishment of regulations for regenerative medical products (for example, regenerative medicines using iPS cells). Indeed, since the Minister of Health, Labour and Welfare issued the first marketing authorisations for two regenerative medical products on September 18 2015, the medical products business in Japan and its regulation have received a good deal of attention.

Stikeman Elliott’s Jeffrey Singer explains why, until recent reforms are approved, M&A parties must play according to the existing and proposed rules

Paul Volcker, former Federal Reserve chairman, spoke exclusively to IFLR about his eponymous rule last month. He said the Volcker Rule, a part of the 2010 Dodd-Frank Act, has carried out his basic intent: banning federally-backed banks from speculative activity. But Volcker believes that more clarity is needed over the regulation.

Something for boards to aspire to European boards are finally prioritising the implementation of defence plans against activist investors as volumes look set to break records.

Still with Dentons, the headline in Asia last month was that it would be adding more numbers to its headcount when it agreed merger terms with GADENS in Australia and RODYK & DAVIDSON in Singapore. This follows a number of other mergers the firm has pursued across the globe in the last two to three years.

Counsel in China have revealed a lack of enforcement of the country's amended Company Law by local officials, as the central government seeks to ease restrictions on foreign investment enterprises (FIEs).

GDP-linked warrants issued as part of Ukraine's $18 billion debt exchange contain unprecedented creditor protections, making them the closest thing possible to having equity in a country.

So, which is it to be? Liquid bond markets or highly capitalised banks?

China's long battle to get the renminbi (RMB) included in the IMF's reserve currency basket has been well documented, right up to the point it achieved that goal on November 30. There is little doubt that the move will help pave the way for wider use of RMB globally.

Here's a cheery Christmas quandary: would you rather be fined or publicly shamed? Back in November, the UK Takeover Panel publicly censured Credit Suisse, Freshfields Bruckhaus Deringer and Holman Fenwick Willan over the way they handled the 2010 creation of Bumi, a London-listed miner of Indonesian coal.